Updates on CAR-T in Multiple Myeloma

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Updates on CAR-T in Multiple Myeloma

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Identifying and Managing Major Toxicities of CAR-T Therapy in Multiple Myeloma

By UChicago Medicine FEATURING Satyajit Kosuri

88 views

October 20, 2022

Comments 0

Patient Selection for Ciltacabtagene Autoleucel Therapy in R/R MM

Maximilian Merz

121 views

CARTITUDE-1: 2 Years Post-LPI Update on the Phase 1b/2 Study of Cilt…

UCSF School of Medicine

T. Martin

224 views

SOHO Brazil 2022 on CAR-T in Refractory MM: When Is the Precise Mome…

SOHO Brazil 2022

M. Bishop, P. Scheinberg

141 views

Myeloma 2022: Challenges and Path Forward

UChicago Medicine

A. Jakubowiak

563 views

CAR T-Cell Therapy Side Effects for Blood Cancers

GRACE

A. Goodman

2.3K views

CAR-T Therapy in Myeloma: What's Here and What's Coming Soon

Rahul Banerjee

615 views

SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Pro C…

SOHO 2022 Tenth Annual Meeting

T. Martin

254 views

SOHO 2022: CAR T-Cell in MM - When To Use Now, Where Are We Going?

SOHO 2022 Tenth Annual Meeting

N. S. Raje

107 views

Triple Refractory MM Patients: Learnings From the MAMMOTH and the Lo…

Enrique Ocio

132 views

CAR-T in MM: Benefits of a Treatment-Free Interval

Shaji Kumar

180 views

Summary of the MAMMOTH Trial in R/R Myeloma

Saurabh Chhabra

503 views

MAMMOTH Trial: Myeloma Outcomes Post Anti-CD38 MoAbs

Zhubin Gahvari

222 views

ASH 2022 Outcomes of Penta-Refractory MM Patients Based on Access to…

ASH 2022 Conference Coverage

S. Atrash

139 views

ASH 2022 Neurotoxicity With Motor Symptoms After BCMA-Directed CAR-T…

ASH 2022 Conference Coverage

S. Parekh

74 views

Treating Multiple Myeloma: The Cure Is Within Reach - Goals of Curre…

Indy Hematology Review

K. Anderson

1.3K views